Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis

  • End date
    Oct 1, 2030
  • participants needed
  • sponsor
    Sherief Abd-Elsalam
Updated on 30 January 2021


Clinical study evaluating selective or nonselective beta blockers use and fracture risk in patients with primary osteoporosis


Clinical study evaluating selective or nonselective beta blockers use and if there is fracture risk in patients with primary osteoporosis

Condition Beta Blocker Toxicity
Treatment nonselective beta blocker, cardio-selective beta blocker group, alendronate sodium, alendronate sodium
Clinical Study IdentifierNCT04704947
SponsorSherief Abd-Elsalam
Last Modified on30 January 2021


Yes No Not Sure

Inclusion Criteria

Is your age greater than or equal to 50 yrs?
Gender: Male or Female
Do you have any of these conditions: Do you have Beta Blocker Toxicity??
Male & female osteoporotic patient aged 50 years
Hypertensive & normotensive patients
BMD T-score 2.5 or more SD below peak bone mass

Exclusion Criteria

Patients on drugs that may improve osteoporosis disease state such as
Angiotensin converting enzyme inhibitor (ACEI) or Angiotensin receptor blockers (ARBs), Thiazide diuretic, Nitrates, Spironolactone, Statins
Patients on drugs that may worsen osteoporosis disease state such as
Corticosteroids, Loop diuretics, Anticonvulsants, Antidepressants, Aromatase
inhibitors, Thyroid replacement therapy and Proton pump inhibitors
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note